Market Exclusive

United Therapeutics (NASDAQ:UTHR) reported earnings of $5.57 per share beating Walls Streets expectations.

United Therapeutics (NASDAQ:UTHR) reported Q1 2018 earnings this Morning, coming in at $5.57 per share, beating Wall Street’s estimates of $3.62 per Share. Revenue for the quarter came in at $389.20 million missing the streets estimates of $393.96 million Recent Insider Trading for United Therapeutics (NASDAQ:UTHR)

Dividend History for United Therapeutics (NASDAQ:UTHR)

Recent Trading for United Therapeutics (NASDAQ:UTHR) Shares of United Therapeutics closed the previous trading session at 112.38 up +0.71 0.64% with 111.80000305175781 shares trading hands.

Exit mobile version